Brett Andrew King MD, PhD
Assistant Professor of Dermatology; Medical Director, Yale Dermatology-Middlebury
Dr. Brett King is Assistant Professor of Dermatology, specializing in skin diseases recalcitrant to first-line therapies. He also conducts investigator-initiated clinical trials to try to identify new treatments for skin disorders. He sees patients at Yale Dermatology Associates in New Haven, Yale Dermatology-Middlebury, and the West Haven VA.
Dr. King provides care of patients with all dermatologic conditions, with special interest in:
atopic dermatitis (eczema)
autoimmune blistering diseases such as pemphigus vulgaris and bullous pemphigoid
autoimmune connective tissue diseases such as morphea and systemic sclerosis (scleroderma)
inflammatory disorders such as lichen planus, pityriasis rubra pilaris, sarcoidosis and granuloma annulare
pruritus (itch) and delusions of parasitosis.
He is experienced with the use of systemic medications including retinoids, methotrexate, cyclosporine, azathioprine (Imuran®), mycophenolate mofetil (Cellcept®), tofacitinib (Xeljanz®), and the ‘biologics’ (e.g. etanercept (Enbrel®), adalimumab (Humira®), infliximab (Remicade®) and ustekinumab (Stelara®)), as well as phototherapy.
Dr. King received his B.A. at the University of California at Santa Cruz, his Ph.D. from Stanford University and his M.D. from Yale University School of Medicine. He completed medical internship at Massachusetts General Hospital and dermatology residency at Yale University School of Medicine.
Education & Training
- University of California at Santa Cruz (1992)
- Stanford University (2000)
- Yale University School of Medicine (2005)
- Yale-New Haven Hospital, Dermatology (2006 - 2009)
- Massachusetts General Hospital, Internal Medicine (2005 - 2006)
- Yale-New Haven Hospital, Dermatology (2009 - 2010)
- Board Certification
- Dermatology, Board Certified (2009)